NeutriSci International (FRA:1N9) OCF Yield %: -30.85 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NeutriSci International OCF Yield %?

NeutriSci International FRA:1N9 OCF Yield % is -30.85 as of Jul. 18, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, NeutriSci International's Trailing 12-Month Cash Flow from Operations is €-0.18 Mil, and Market Cap is €0.59 Mil. Therefore, NeutriSci International's OCF Yield % for today is -30.85%.

The historical rank and industry rank for NeutriSci International's OCF Yield % or its related term are showing as below:

FRA:1N9' s OCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -30.85

FRA:1N9's OCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.55 vs FRA:1N9: -30.85

NeutriSci International's OCF Margin % for the quarter that ended in Sep. 2023 was %.

NeutriSci International OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

NeutriSci International OCF Yield % Related Terms

NeutriSci International OCF Yield % Historical Data

* Premium members only.

The historical data trend for NeutriSci International's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeutriSci International OCF Yield % Chart

NeutriSci International Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.07 -66.91 -9.36 -12.38 -10.21

NeutriSci International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.09 -14.92 -42.35 -152.45 -17.93

FRA:1N9 vs ZTS, NBIX: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NeutriSci International's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeutriSci International OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NeutriSci International's OCF Yield % distribution charts can be found below:

* The bar in red indicates where NeutriSci International's OCF Yield % falls into.


NeutriSci International OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

NeutriSci International's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.115 / 1.1261632
=-10.21%

NeutriSci International's annualized OCF Yield % for the quarter that ended in Sep. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.004 * 4 / 0.089212
=-17.93%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -30.85 mean?
NeutriSci International (FRA:1N9) has a OCF Yield % of -30.85 as of Jul. 18, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on NeutriSci International and its competitors.
Is NeutriSci International's OCF Yield % too high?
NeutriSci International's current OCF Yield % is -30.85.
How does NeutriSci International's OCF Yield % compare to ZTS and NBIX?
NeutriSci International's OCF Yield % of -30.85 can be compared against companies in the Drug Manufacturers industry. The industry median OCF Yield % is 3.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on NeutriSci International and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeutriSci International's current OCF Yield % is -30.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeutriSci International stock overvalued right now?
NeutriSci International (FRA:1N9) has a current OCF Yield % of -30.85. The current OCF Yield % is -30.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For NeutriSci International (FRA:1N9), the current OCF Yield % is -30.85 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeutriSci International Business Description

Address 609 Granville Street, Suite 1600, Vancouver, BC, CAN, V7Y 1C3
NeutriSci International Inc specializes in the production and formulation of nutraceutical products within the B2B industry. By incorporating natural ingredients, it implements industry disrupting patent pending Cryolization Technology to provide B2B partners with the ability to create unparalleled products. Using patent pending proprietary ingredients, technologies, and IP, it can help bring to market effective, solution-oriented products that meet the needs of consumers. The company continues to develop emerging sales channels in the USA, European, Asian & South American markets.